Dies ist eine Übersichtsseite mit Metadaten zu dieser wissenschaftlichen Arbeit. Der vollständige Artikel ist beim Verlag verfügbar.
Vascular Anomalies Classification: Recommendations From the International Society for the Study of Vascular Anomalies
1.356
Zitationen
15
Autoren
2015
Jahr
Abstract
Vascular anomalies represent a spectrum of disorders from a simple "birthmark" to life- threatening entities. Incorrect nomenclature and misdiagnoses are commonly experienced by patients with these anomalies. Accurate diagnosis is crucial for appropriate evaluation and management, often requiring multidisciplinary specialists. Classification schemes provide a consistent terminology and serve as a guide for pathologists, clinicians, and researchers. One of the goals of the International Society for the Study of Vascular Anomalies (ISSVA) is to achieve a uniform classification. The last classification (1997) stratified vascular lesions into vascular malformations and proliferative vascular lesions (tumors). However, additional disease entities have since been identified that are complex and less easily classified by generic headings, such as capillary malformation, venous malformation, lymphatic malformation, etc. We hereby present the updated official ISSVA classification of vascular anomalies. The general biological scheme of the classification is retained. The section on tumors has been expanded and lists the main recognized vascular tumors, classified as benign, locally aggressive or borderline, and malignant. A list of well-defined diseases is included under each generic heading in the "Simple Vascular Malformations" section. A short definition is added for eponyms. Two new sections were created: one dealing with the malformations of individually named vessels (previously referred to as "truncular" malformations); the second groups lesions of uncertain or debated nature (tumor versus malformation). The known genetic defects underlying vascular anomalies are included in an appendix. This classification is meant to be a framework, acknowledging that it will require modification as new scientific information becomes available.
Ähnliche Arbeiten
Hemangiomas and Vascular Malformations in Infants and Children
1982 · 3.287 Zit.
Propranolol for Severe Hemangiomas of Infancy
2008 · 2.323 Zit.
HEMANGIOPERICYTOMA A VASCULAR TUMOR FEATURING ZIMMERMANNʼS PERICYTES
1942 · 1.441 Zit.
Lymphangiogenesis: Molecular Mechanisms and Future Promise
2010 · 1.429 Zit.
Recurrent BRAF mutations in Langerhans cell histiocytosis
2010 · 1.218 Zit.
Autoren
Institutionen
- Université Paris Cité(FR)
- Délégation Paris 7(FR)
- Assistance Publique – Hôpitaux de Paris(FR)
- Hôpital Lariboisière(FR)
- Lenox Hill Hospital(US)
- Northwell Health(US)
- University of Cincinnati(US)
- Cincinnati Children's Hospital Medical Center(US)
- Harvard University(US)
- Boston Children's Hospital(US)
- Hospital de Sant Pau(ES)
- Medical College of Wisconsin(US)
- University of California, San Francisco(US)
- Columbia University(US)
- Hospital Universitario La Paz(ES)
- Sydney Children’s Hospitals Network(AU)
- Johns Hopkins University(US)
- Johns Hopkins Hospital(US)
- Centre Hospitalier Universitaire Sainte-Justine(CA)
- Université de Montréal(CA)
- University of British Columbia(CA)
- de Duve Institute(BE)
- UCLouvain(BE)
- Cliniques Universitaires Saint-Luc(BE)